Perrigo (PRGO) Treasury Shares (2013 - 2025)
Perrigo's (PRGO) quarterly Treasury Shares came in at $3.1 million in Q4 2025, up 18.13% year-on-year from $2.6 million in Q4 2024, and up 18.13% on a QoQ basis from $2.6 million in Q4 2024.
Perrigo (PRGO) Treasury Shares (2013 - 2025) Analysis & Trends
Perrigo (PRGO) has 11 years of Treasury Shares data on file, last reported at $3.1 million in Q4 2025.
- On a quarterly basis, Treasury Shares rose 18.13% year-over-year to $3.1 million in Q4 2025; TTM through Dec 2025 was $3.1 million, a 18.13% increase from a year earlier, with the FY2025 full-year figure at $3.1 million, up 18.13% from the prior year.
- Treasury Shares for Q4 2025 stood at $3.1 million, up from $2.6 million in the prior quarter.
- Over the last five years, Treasury Shares for PRGO reached as high as $3.1 million in Q4 2025 and fell as low as $236000.0 in Q4 2021.
- Historically, Treasury Shares has averaged $1.7 million across 5 years, with a median of $1.3 million in 2023.
- Across the five-year window, Treasury Shares slumped 68.58% in 2021 and surged 352.97% in 2022, its largest moves.
- Year by year, Treasury Shares stood at $236000.0 in 2021, then surged by 352.97% to $1.1 million in 2022, then gained by 18.9% to $1.3 million in 2023, then surged by 104.8% to $2.6 million in 2024, then advanced by 18.13% to $3.1 million in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were $3.1 million in Q4 2025, $2.6 million in Q4 2024, and $1.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.08 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Dec 31, 2021 | 236,000.00 |
| Dec 31, 2021 | 236,000.00 |
| Dec 31, 2020 | 751,000.00 |
| Dec 31, 2020 | 751,000.00 |
| Dec 31, 2019 | 1.21 Mn |
| Dec 31, 2019 | 1.21 Mn |
| Dec 31, 2018 | 728,000.00 |
| Dec 31, 2018 | 728,000.00 |
| Dec 31, 2017 | 599,000.00 |
| Dec 31, 2017 | 599,000.00 |
| Jun 28, 2014 | 182,000.00 |
| Jun 28, 2014 | 182,000.00 |